Tysabri (natalizumab)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Progressive Multifocal Leukoencephalopathy (addition)
MRI findings may be apparent before...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts